Boston Scientific‘s REBEL bare-metal platinum chromium coronary stent received FDA approval in the U.S. following European clearance back in February. This is the same stent as the drug eluting Promus PREMIER, but without the Everolimus coating.
The company touts the stent’s excellent visibility under fluoroscopy and an architecture that gives it high radial and axial strength while having the lowest recoil among the competing stents. The REBEL is available with diameters from 2.25 mm to 4.50 mm and lengths of 8 mm to 32 mm.
Here’s a company video presenting the REBEL:
Product page: REBEL Stent System…